Early-onset, conjugal, twin-discordant, and clusters of sporadic ALS: Pathway to discovery of etiology via lifetime exposome research
暂无分享,去创建一个
C. Raoul | G. Kisby | W. Camu | V. Palmer | J. Vernoux | J. Reis | E. Lagrange | B. Horowitz | R. Valdes Angues | P. Spencer
[1] G. Kisby,et al. MGMT, a risk factor for both genetic and environmental forms of dementia , 2022, Alzheimer's & dementia : the journal of the Alzheimer's Association.
[2] P. Preux,et al. Spatio-temporal clustering of amyotrophic lateral sclerosis in France: A population-based study , 2022, European Journal of Epidemiology.
[3] G. Román,et al. Amyotrophic lateral sclerosis from genotoxins alone? , 2022, The Lancet Neurology.
[4] K. Lunetta,et al. Genome‐wide association and multi‐omics studies identify MGMT as a novel risk gene for Alzheimer's disease among women , 2022, Alzheimer's & dementia : the journal of the Alzheimer's Association.
[5] T. Bird,et al. Progress in Amyotrophic Lateral Sclerosis Gene Discovery , 2022, Neurology: Genetics.
[6] N. T. Dhruv,et al. A focus on the neural exposome , 2022, Neuron.
[7] Stephen A. Goutman,et al. Emerging insights into the complex genetics and pathophysiology of amyotrophic lateral sclerosis , 2022, The Lancet Neurology.
[8] T. Hansen,et al. High incidence of amyotrophic lateral sclerosis in the Faroe Islands 2010–2020 , 2022, Annals of clinical and translational neurology.
[9] A. Andrew,et al. Airborne lead and polychlorinated biphenyls (PCBs) are associated with amyotrophic lateral sclerosis (ALS) risk in the U.S. , 2022, The Science of the total environment.
[10] A. Andrew,et al. A perspective on persistent toxicants in veterans and amyotrophic lateral sclerosis: identifying exposures determining higher ALS risk , 2022, Journal of Neurology.
[11] A. Chiò,et al. Unraveling the complex interplay between genes, environment, and climate in ALS , 2021, EBioMedicine.
[12] G. Kisby,et al. Genotoxic Damage During Brain Development Presages Prototypical Neurodegenerative Disease , 2021, Frontiers in Neuroscience.
[13] R. Halden,et al. Systematic and state-of the science review of the role of environmental factors in Amyotrophic Lateral Sclerosis (ALS) or Lou Gehrig's Disease. , 2021, The Science of the total environment.
[14] W. Camu,et al. Reversible sub-acute motor neuron syndrome after mushroom intoxication masquerading as amyotrophic lateral sclerosis , 2021, Amyotrophic lateral sclerosis & frontotemporal degeneration.
[15] M. Hasegawa,et al. An immigrant family with Kii amyotrophic lateral sclerosis/parkinsonism–dementia complex , 2021, Neurological Sciences.
[16] G. Kisby,et al. Mechanisms Underlying Long-Latency Neurodegenerative Diseases of Environmental Origin , 2021, Handbook of Neurotoxicity.
[17] G. Kisby,et al. Role of Hydrazine-Related Chemicals in Cancer and Neurodegenerative Disease. , 2021, Chemical research in toxicology.
[18] A. Doyle,et al. Occupational risk of organophosphates and other chemical and radiative exposure in the aircraft cabin: A systematic review. , 2021, The Science of the total environment.
[19] W. Camu,et al. An amyotrophic lateral sclerosis hot spot in the French Alps associated with genotoxic fungi , 2021, Journal of the Neurological Sciences.
[20] H. Purohit,et al. Myco-remediation of Chlorinated Pesticides: Insights Into Fungal Metabolic System , 2021, Indian Journal of Microbiology.
[21] P. Spencer,et al. Direct and Indirect Neurotoxic Potential of Metal/Metalloids in Plants and Fungi Used for Food, Dietary Supplements, and Herbal Medicine , 2021, Toxics.
[22] R. Vermeulen,et al. Incidence, Prevalence, and Geographical Clustering of Motor Neuron Disease in the Netherlands , 2021, Neurology.
[23] K. Reddy. Amyotrophic Lateral Sclerosis (Als) Disease Clusters in the United States and International Sites: Association With Glacial Lakes and Clay Minerals , 2020 .
[24] A. Miller,et al. Studies in Gyromitra I: the Gyromitra gigas species complex , 2020, Mycological Progress.
[25] T. Albertson,et al. The Toxicity, Pathophysiology, and Treatment of Acute Hydrazine Propellant Exposure: A Systematic Review. , 2020, Military medicine.
[26] G. Kisby,et al. Western Pacific ALS-PDC: Evidence implicating cycad genotoxins , 2020, Journal of the Neurological Sciences.
[27] T. Hansen,et al. Amyotrophic lateral sclerosis in the Faroe Islands – a genealogical study , 2020, Amyotrophic lateral sclerosis & frontotemporal degeneration.
[28] W. Reid. Hypothesis: Mycotoxins Causing Amyotrophic Lateral Sclerosis , 2020 .
[29] J. Vernoux,et al. Warning on False or True Morels and Button Mushrooms with Potential Toxicity Linked to Hydrazinic Toxins: An Update , 2020, Toxins.
[30] P. Spencer. Etiology of Retinal and Cerebellar Pathology in Western Pacific Amyotrophic Lateral Sclerosis and Parkinsonism-Dementia Complex , 2020, Eye and brain.
[31] E. Beghi,et al. Increased risk and early onset of ALS in professional players from Italian Soccer Teams , 2020, Amyotrophic lateral sclerosis & frontotemporal degeneration.
[32] M. Vinceti,et al. Environmental and Occupational Risk Factors of Amyotrophic Lateral Sclerosis: A Population-Based Case-Control Study , 2020, International journal of environmental research and public health.
[33] Nuno Empadinhas,et al. Microbial BMAA and the Pathway for Parkinson’s Disease Neurodegeneration , 2020, Frontiers in Aging Neuroscience.
[34] B. Traynor,et al. The Overlapping Genetics of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia , 2020, Frontiers in Neuroscience.
[35] A. El Harfi,et al. Classifications, properties, recent synthesis and applications of azo dyes , 2020, Heliyon.
[36] P. Preux,et al. Amyotrophic lateral sclerosis spatial epidemiology in the Mount Etna region, Italy , 2019, European Journal of Neurology.
[37] M. Pugh,et al. Amyotrophic Lateral Sclerosis Among Veterans Deployed in Support of Post-9/11 U.S. Conflicts. , 2019, Military medicine.
[38] Kaiyue Zhang,et al. Population-based study of environmental/occupational lead exposure and amyotrophic lateral sclerosis: a systematic review and meta-analysis , 2019, Neurological Sciences.
[39] G. Guillemin,et al. Fungal-contaminated grass and well water and sporadic amyotrophic lateral sclerosis , 2019, Neural regeneration research.
[40] I. Svanberg,et al. Mushroom hunting and consumption in twenty-first century post-industrial Sweden , 2019, Journal of Ethnobiology and Ethnomedicine.
[41] P. Spencer. Hypothesis: Etiologic and Molecular Mechanistic Leads for Sporadic Neurodegenerative Diseases Based on Experience With Western Pacific ALS/PDC , 2019, Front. Neurol..
[42] Denis C. Bauer,et al. Monozygotic twins and triplets discordant for amyotrophic lateral sclerosis display differential methylation and gene expression , 2019, Scientific Reports.
[43] J. Raszeja-Wyszomirska,et al. Acute liver injury, acute liver failure and acute on chronic liver failure: A clinical spectrum of poisoning due to Gyromitra esculenta. , 2019, Annals of hepatology.
[44] A. Chiò,et al. Parkinsonian traits in amyotrophic lateral sclerosis (ALS): a prospective population-based study , 2019, Journal of Neurology.
[45] Luis Carrasco,et al. Searching for Bacteria in Neural Tissue From Amyotrophic Lateral Sclerosis , 2019, Front. Neurosci..
[46] W. Camu,et al. ALS and environment: Clues from spatial clustering? , 2019, Revue neurologique.
[47] G. Guillemin,et al. Fungal Neurotoxins and Sporadic Amyotrophic Lateral Sclerosis , 2018, Neurotoxicity Research.
[48] A. Chiò,et al. Gene-Environment-Time Interactions in Neurodegenerative Diseases: Hypotheses and Research Approaches , 2018, Annals of Neurosciences.
[49] T. H. Nguyen,et al. Global, regional, and national burden of motor neuron diseases 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2018, The Lancet Neurology.
[50] Jessica a. Cohen,et al. Prevalence of Amyotrophic Lateral Sclerosis — United States, 2015 , 2018, MMWR. Morbidity and mortality weekly report.
[51] N. Vanacore,et al. Amyotrophic Lateral Sclerosis and soccer: an internet survey of 29 Italian players. , 2018, Annali dell'Istituto superiore di sanita.
[52] P. Spencer. Formaldehyde, DNA damage, ALS and related neurodegenerative diseases , 2018, Journal of the Neurological Sciences.
[53] W. Brandenburg,et al. Mushroom poisoning epidemiology in the United States , 2018, Mycologia.
[54] M. Sáez,et al. Spatial Assessment of the Association between Long-Term Exposure to Environmental Factors and the Occurrence of Amyotrophic Lateral Sclerosis in Catalonia, Spain: A Population-Based Nested Case-Control Study , 2018, Neuroepidemiology.
[55] A. Chiò,et al. Spatial epidemiology of amyotrophic lateral sclerosis in Piedmont and Aosta Valley, Italy: a population‐based cluster analysis , 2018, European journal of neurology.
[56] J. Riancho,et al. The increasing importance of environmental conditions in amyotrophic lateral sclerosis , 2018, International Journal of Biometeorology.
[57] K. Srivenugopal,et al. S-phase Specific Downregulation of Human O6-Methylguanine DNA Methyltransferase (MGMT) and its Serendipitous Interactions with PCNA and p21cip1 Proteins in Glioma Cells , 2018, Neoplasia.
[58] O. Comandini,et al. Sardinia: Mycovisions from a charming land , 2018 .
[59] T. Suhara,et al. A migration case of Kii amyotrophic lateral sclerosis/parkinsonism dementia complex with the shortest stay in the endemic area and the longest incubation to develop the disease , 2017, Journal of Clinical Neuroscience.
[60] P. Nunn. 50 years of research on α-amino-β-methylaminopropionic acid (β-methylaminoalanine). , 2017, Phytochemistry.
[61] Luis Carrasco,et al. Fungal infection in neural tissue of patients with amyotrophic lateral sclerosis , 2017, Neurobiology of Disease.
[62] Greg Maguire. Amyotrophic lateral sclerosis as a protein level, non-genomic disease: Therapy with S2RM exosome released molecules , 2017, World journal of stem cells.
[63] Y-H Taguchi,et al. Genetic Association between Amyotrophic Lateral Sclerosis and Cancer , 2017, Genes.
[64] A. Chiò,et al. Occupations and amyotrophic lateral sclerosis: are jobs exposed to the general public at higher risk? , 2017, European journal of public health.
[65] Marianthi-Anna Kioumourtzoglou,et al. Occupational formaldehyde and amyotrophic lateral sclerosis , 2017, European Journal of Epidemiology.
[66] M. Macleod,et al. Conjugal amyotrophic lateral sclerosis: a case report from Scotland , 2017, BMC Neurology.
[67] J. Langston,et al. The MPTP Story , 2017, Journal of Parkinson's disease.
[68] W. Reid. Immunosuppression & Mycotoxins Causing Amyotrophic Lateral Sclerosis , 2017 .
[69] E. Beghi,et al. Variation in worldwide incidence of amyotrophic lateral sclerosis: a meta-analysis , 2016, International journal of epidemiology.
[70] S. Pulst,et al. Population-based risks for cancer in patients with ALS , 2016, Neurology.
[71] Stuart Batterman,et al. Association of Environmental Toxins With Amyotrophic Lateral Sclerosis. , 2016, JAMA neurology.
[72] M. Klug,et al. Motor neuron disease mortality rates in U.S. states are associated with well water use , 2016, Amyotrophic lateral sclerosis & frontotemporal degeneration.
[73] N. Wareham,et al. Long-term physical activity: an exogenous risk factor for sporadic amyotrophic lateral sclerosis? , 2016, Amyotrophic lateral sclerosis & frontotemporal degeneration.
[74] M. Zappia,et al. The epidemiology of amyotrophic lateral sclerosis in the Mount Etna region: a possible pathogenic role of volcanogenic metals , 2016, European journal of neurology.
[75] Angela M. Malek,et al. The epidemiology of amyotrophic lateral sclerosis. , 2016, Handbook of clinical neurology.
[76] J. P. Kaiser,et al. Epigenetic Regulation in Environmental Chemical Carcinogenesis and its Applicability in Human Health Risk Assessment , 2015, International journal of toxicology.
[77] F. Coppedè,et al. DNA damage in neurodegenerative diseases. , 2015, Mutation research.
[78] Luis Carrasco,et al. Evidence for Fungal Infection in Cerebrospinal Fluid and Brain Tissue from Patients with Amyotrophic Lateral Sclerosis , 2015, International journal of biological sciences.
[79] G. Kisby,et al. Environmental Neurotoxins Linked to a Prototypical Neurodegenerative Disease , 2015 .
[80] Z. Janka,et al. Proteomic analysis of cerebrospinal fluid in Alzheimer's disease: wanted dead or alive. , 2015, Journal of Alzheimer's disease : JAD.
[81] J. Little,et al. A Meta-Analysis of Observational Studies of the Association Between Chronic Occupational Exposure to Lead and Amyotrophic Lateral Sclerosis , 2014, Journal of occupational and environmental medicine.
[82] M. Druet‐Cabanac,et al. Searching for a link between the L-BMAA neurotoxin and amyotrophic lateral sclerosis: a study protocol of the French BMAALS programme , 2014, BMJ Open.
[83] Stephen A. Goutman,et al. Environmental Risk Factors and Amyotrophic Lateral Sclerosis (ALS): A Case-Control Study of ALS in Michigan , 2014, PloS one.
[84] R. Cantello,et al. A rare case of conjugal amyotrophic lateral sclerosis , 2014, Journal of Neurology.
[85] H. Seguchi,et al. Amyotrophic lateral sclerosis and parkinsonism in Papua, Indonesia: 2001–2012 survey results , 2014, BMJ Open.
[86] E. Beghi. Are professional soccer players at higher risk for ALS? , 2013, Amyotrophic lateral sclerosis & frontotemporal degeneration.
[87] L. Pinkerton,et al. Assessment of ALS mortality in a cohort of formaldehyde-exposed garment workers , 2013, Amyotrophic lateral sclerosis & frontotemporal degeneration.
[88] A. Al-Chalabi,et al. Amyotrophic lateral sclerosis and cancer: A register-based study in Sweden , 2013, Amyotrophic lateral sclerosis & frontotemporal degeneration.
[89] E. Stommel,et al. Spatial analysis of amyotrophic lateral sclerosis in Northern New England, USA, 1997–2009 , 2013, Muscle & nerve.
[90] A. Mešić,et al. Mycophilic or Mycophobic? Legislation and Guidelines on Wild Mushroom Commerce Reveal Different Consumption Behaviour in European Countries , 2013, PloS one.
[91] J. Sperry,et al. Natural products containing a nitrogen-nitrogen bond. , 2013, Journal of natural products.
[92] A. Chiò,et al. Amyotrophic lateral sclerosis in Piedmont (Italy): A Bayesian spatial analysis of the incident cases , 2013, Amyotrophic lateral sclerosis & frontotemporal degeneration.
[93] C. Pritchard,et al. A Case-Study Survey of an Eight-year Cluster of Motor Neurone Disease (MND) Referrals in a Rural English Village: Exploring Possible Aetiological Influences in a Hypothesis Stimulating Study , 2013 .
[94] Damià Barceló,et al. Removal of pharmaceuticals, polybrominated flame retardants and UV-filters from sludge by the fungus Trametes versicolor in bioslurry reactor. , 2012, Journal of hazardous materials.
[95] A. Al-Chalabi,et al. Young-onset amyotrophic lateral sclerosis: historical and other observations. , 2012, Brain : a journal of neurology.
[96] R. Fry,et al. Unraveling 50-Year-Old Clues Linking Neurodegeneration and Cancer to Cycad Toxins: Are microRNAs Common Mediators? , 2012, Front. Gene..
[97] K. Kuča,et al. GYROMITRIN, MUSHROOM TOXIN OF GYROMITRA SPP. , 2012 .
[98] Rebecca A. B. Burton,et al. Conjugal Amyotrophic Lateral Sclerosis , 2012, Proceedings.
[99] Kristina W. Kintziger,et al. Wild Mushroom Exposures in Florida, 2003–2007 , 2011, Public health reports.
[100] M. Druet‐Cabanac,et al. Contribution of geolocalisation to neuroepidemiological studies: Incidence of ALS and environmental factors in Limousin, France , 2011, Journal of the Neurological Sciences.
[101] G. Kisby,et al. Is Neurodegenerative Disease a Long-Latency Response to Early-Life Genotoxin Exposure? , 2011, International journal of environmental research and public health.
[102] L. Samson,et al. The Cycad Genotoxin MAM Modulates Brain Cellular Pathways Involved in Neurodegenerative Disease and Cancer in a DNA Damage-Linked Manner , 2011, PloS one.
[103] K. Rothman,et al. The relation between amyotrophic lateral sclerosis and inorganic selenium in drinking water: a population-based case-control study , 2010, Environmental health : a global access science source.
[104] T. Tango,et al. Temporal trends and geographic clusters of mortality from amyotrophic lateral sclerosis in Japan, 1995–2004 , 2010, Journal of the Neurological Sciences.
[105] A. Al-Chalabi,et al. An estimate of amyotrophic lateral sclerosis heritability using twin data , 2010, Journal of Neurology, Neurosurgery & Psychiatry.
[106] M. Rantalainen,et al. Structural shifts of gut microbiota as surrogate endpoints for monitoring host health changes induced by carcinogen exposure. , 2010, FEMS microbiology ecology.
[107] S. Schmidt,et al. Original Contribution Association Between Blood Lead and the Risk of Amyotrophic Lateral Sclerosis , 2010 .
[108] M. Vinceti,et al. Possible involvement of overexposure to environmental selenium in the etiology of amyotrophic lateral sclerosis: a short review. , 2010, Annali dell'Istituto superiore di sanita.
[109] A. Oliveira,et al. Conjugal amyotrophic lateral sclerosis in Brazil. , 2009, Arquivos de Neuro-Psiquiatria.
[110] C. Armon. Smoking may be considered an established risk factor for sporadic ALS , 2009, Neurology.
[111] M. Thun,et al. Prospective study of chemical exposures and amyotrophic lateral sclerosis , 2009, Journal of Neurology, Neurosurgery, and Psychiatry.
[112] W. Bradley,et al. Cyanobacteria and BMAA exposure from desert dust: A possible link to sporadic ALS among Gulf War veterans , 2009, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.
[113] H. Andersson,et al. Agaritine content of 53 Agaricus species collected from nature , 2009, Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment.
[114] E. Stommel,et al. A cluster of amyotrophic lateral sclerosis in New Hampshire: A possible role for toxic cyanobacteria blooms , 2009, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.
[115] A. Chiò,et al. ALS in Italian professional soccer players: The risk is still present and could be soccer-specific , 2009, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.
[116] A. Al-Chalabi,et al. Geographical Clustering of Amyotrophic Lateral Sclerosis in South-East England: A Population Study , 2008, Neuroepidemiology.
[117] S. Grambow,et al. Amyotrophic Lateral Sclerosis among 1991 Gulf War Veterans: Evidence for a Time-Limited Outbreak , 2008, Neuroepidemiology.
[118] George Turabelidze,et al. An epidemiologic investigation of amyotrophic lateral sclerosis in Jefferson County, Missouri, 1998-2002. , 2008, Neurotoxicology.
[119] S. Kuzuhara. [ALS-parkinsonism-dementia complex of the Kii peninsula of Japan (Muro disease). Historical review, epidemiology and concept]. , 2007, Rinsho shinkeigaku = Clinical neurology.
[120] P. Comba,et al. Geographic distribution of amyotrophic lateral sclerosis through motor neuron disease mortality data , 2007, European Journal of Epidemiology.
[121] G. Schellenberg,et al. Cycad exposure and risk of dementia, MCI, and PDC in the Chamorro population of Guam , 2007, Neurology.
[122] F. Venza,et al. Journal of Ethnobiology and Ethnomedicine Open Access Wild Food Plants of Popular Use in Sicily , 2022 .
[123] A. M. Leathem,et al. Poisoning due to raw Gyromitra esculenta (false morels) west of the Rockies. , 2007, CJEM.
[124] A. Al-Chalabi,et al. Three soccer playing friends with simultaneous amyotrophic lateral sclerosis , 2007, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.
[125] M. de Carvalho,et al. Young‐onset sporadic amyotrophic lateral sclerosis: A distinct nosological entity? , 2007, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.
[126] David E. Williams,et al. Behavioral and neurological correlates of ALS-parkinsonism dementia complex in adult mice fed washed cycad flour , 2007, NeuroMolecular Medicine.
[127] A. Binazzi,et al. Amyotrophic lateral sclerosis in an Italian professional soccer player. , 2006, Parkinsonism & related disorders.
[128] S. Woodward,et al. Wild-gathered fungi for health and rural livelihoods , 2006, Proceedings of the Nutrition Society.
[129] Mark A Brown. Toxicological assessments of Gulf War veterans , 2006, Philosophical Transactions of the Royal Society B: Biological Sciences.
[130] N. Dessì,et al. Conjugal amyotrophic lateral sclerosis: a report on a couple from Sardinia, Italy , 1998, The Italian Journal of Neurological Sciences.
[131] T. Cajthaml,et al. Structure selectivity in degradation and translocation of polychlorinated biphenyls (Delor 103) with a Pleurotus ostreatus (oyster mushroom) culture. , 2005, Chemosphere.
[132] Albert C Ludolph,et al. On the decline and etiology of high‐incidence motor system disease in West Papua (southwest New Guinea) , 2005, Movement disorders : official journal of the Movement Disorder Society.
[133] E. Granieri,et al. Amyotrophic lateral sclerosis, rural environment and agricultural work in the Local Health District of Ferrara, Italy, in the years 1964–1998 , 2005, Journal of Neurology.
[134] A. Chiò,et al. Severely increased risk of amyotrophic lateral sclerosis among Italian professional football players. , 2005, Brain : a journal of neurology.
[135] M. Thun,et al. Prospective study of military service and mortality from ALS , 2005, Neurology.
[136] Sohei Yoshida,et al. Changes in the incidence of amyotrophic lateral sclerosis in Wakayama, Japan , 2005, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.
[137] R. Mai,et al. Conjugal amyotrophic lateral sclerosis: toxic clustering or chance? , 1997, The Italian Journal of Neurological Sciences.
[138] K. Teschke,et al. Occupational exposure to chemical agents in the paper industry , 2004, International archives of occupational and environmental health.
[139] J. Mendell,et al. Three cases of amyotrophic lateral sclerosis in a common occupational environment , 1987, Journal of Neurology.
[140] L. Wilkins,et al. Occurrence of amyotrophic lateral sclerosis among Gulf War veterans , 2003, Neurology.
[141] R. Haley. Excess incidence of ALS in young Gulf War veterans , 2003, Neurology.
[142] A C Gatrell,et al. Spatial clustering of amyotrophic lateral sclerosis in Finland at place of birth and place of death. , 2003, American journal of epidemiology.
[143] P. Corcia,et al. A clustering of conjugal amyotrophic lateral sclerosis in southeastern France. , 2003, Archives of neurology.
[144] D. Galasko,et al. Amyotrophic lateral sclerosis and parkinsonism-dementia complex of Guam: changing incidence rates during the past 60 years. , 2003, American journal of epidemiology.
[145] A. Malaspina,et al. Disease clustering: the example of ALS, PD, dementia and hereditary ataxias in Italy. , 2002, Functional neurology.
[146] David M. Umbach,et al. Lead Exposure and Amyotrophic Lateral Sclerosis , 2002, Epidemiology.
[147] A. Chiò,et al. Conjugal amyotrophic lateral sclerosis: suggestion for the implication of environmental factors , 2001, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.
[148] E. Gogolashvili,et al. Detoxication of hydrazine in waste waters , 2001 .
[149] J. Hugon,et al. Damage and repair of nerve cell DNA in toxic stress. , 1999, Drug metabolism reviews.
[150] Re-evaluation of some organic chemicals, hydrazine and hydrogen peroxide. Proceedings of the IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, France, 17-24 February 1998. , 1999, IARC monographs on the evaluation of carcinogenic risks to humans.
[151] R. B. Davies,et al. Geographical epidemiology of residence of patients with motor neuron disease in Lancashire and south Cumbria , 1998, Journal of neurology, neurosurgery, and psychiatry.
[152] T. Kihira,et al. Epidemiology of motor neuron disease in the Kii Peninsula of Japan, 1989–1993: Active or disappearing focus? , 1998, Journal of the Neurological Sciences.
[153] T. Nomiyama,et al. Evidence on N-acetyltransferase allele-associated metabolism of hydrazine in Japanese workers. , 1998, Journal of occupational and environmental medicine.
[154] C. Hawkes,et al. British motor neuron disease twin study. , 1997, Journal of neurology, neurosurgery, and psychiatry.
[155] G. Román,et al. Neuroepidemiology of amyotrophic lateral sclerosis: clues to aetiology and pathogenesis. , 1996, Journal of neurology, neurosurgery, and psychiatry.
[156] R. Orrell,et al. Patterns of inheritance in United Kingdom families with amyotrophic lateral sclerosis. , 1996 .
[157] J. De Pedro-Cuesta,et al. An epidemic-like cluster of motor neuron disease in a Swedish county during the period 1973-1984. , 1996, Neuroepidemiology.
[158] K. M. Chen,et al. [Disappearance of ALS from Guam: implications for exogenous causes]. , 1995, Rinsho shinkeigaku = Clinical neurology.
[159] N. Saravanan,et al. Bis-hydrazine metal maleates and fumarates: Preparation, spectral and thermal studies , 1995, Proceedings / Indian Academy of Sciences.
[160] G. Kisby,et al. Cycad toxin-induced damage of rodent and human pancreatic β-cells , 1995 .
[161] B. Tóth,et al. Gyromitra esculenta mushroom: a comparative assessment of its carcinogenic potency. , 1994, In vivo.
[162] R. C. Shank,et al. Hydralazine and other hydrazine derivatives and the formation of DNA adducts. , 1994, Toxicology and applied pharmacology.
[163] M. Billiard,et al. Conjugal amyotrophic lateral sclerosis , 1994, Neurology.
[164] L. Morrison,et al. Conjugal amyotrophic lateral sclerosis , 1993, Neurology.
[165] J. Slattery,et al. Risk factors for motor neuron disease: a case-control study based on patients from the Scottish Motor Neuron Disease Register. , 1993, Journal of neurology, neurosurgery, and psychiatry.
[166] J. S. Gecan,et al. Toxic Mushroom Contamination of Wild Mushrooms in Commercial Distribution. , 1993, Journal of food protection.
[167] M. Giagheddu,et al. Amyotrophic lateral sclerosis in Sardinia, Italy: an epidemiologic study , 1993, Acta neurologica Scandinavica.
[168] L. C. Leite,et al. Carbon-centered free radical formation during the metabolism of hydrazine derivatives by neutrophils. , 1993, Biochemical pharmacology.
[169] Deanna D. Belli,et al. Pathologic findings in the retinal pigment epitheliopathy associated with the amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam. , 1993, Ophthalmology.
[170] B. Tóth. Teratogenic hydrazines: a review. , 1993, In vivo.
[171] A. Chiò,et al. Risk factors in motor neuron disease: a case-control study. , 1991, Neuroepidemiology.
[172] B. Tóth,et al. Poisoning by Gyromitra esculenta–a review , 1991, Journal of applied toxicology : JAT.
[173] A. Ludolph,et al. Slow toxins, biologic markers, and long‐latency neurodegenerative disease in the western Pacific region , 1991, Neurology.
[174] B. Tóth. Carcinogenic fungal hydrazines. , 1991, In vivo.
[175] D. Vassilopoulos,et al. Amyotrophic lateral sclerosis in southern Greece: an epidemiologic study. , 1991, Neuroepidemiology.
[176] A. Gatrell,et al. Amyotrophic lateral sclerosis in Lancashire and South Cumbria, England, 1976-1986. A geographical study. , 1990, Archives of neurology.
[177] J. Taylor,et al. Amyotrophic lateral sclerosis. A case-control study following detection of a cluster in a small Wisconsin community. , 1990, Archives of neurology.
[178] C. Hawkes,et al. MOTONEURON DISEASE: A DISORDER SECONDARY TO SOLVENT EXPOSURE? , 1989, The Lancet.
[179] K. Radhakrishnan,et al. Conjugal motor neurone disease. , 1987, The Journal of the Association of Physicians of India.
[180] M. Carreras,et al. Risk factors for amyotrophic lateral sclerosis in Sardinia, Italy , 1989 .
[181] J. P. Davis,et al. Evidence for clustering of amyotrophic lateral sclerosis in Wisconsin. , 1989, Journal of clinical epidemiology.
[182] A. Iannone,et al. Free radical activation of monomethyl and dimethyl hydrazines in isolated hepatocytes and liver microsomes. , 1989, Free radical biology & medicine.
[183] M. Carreras,et al. Motor neuron disease in the province of Ferrara, Italy, in 1964–1982 , 1988, Neurology.
[184] P. Khanna,et al. Nitrosamine in leather dust extracts. , 1988, British journal of industrial medicine.
[185] V. Palmer,et al. CYCAD USE AND MOTOR NEURONE DISEASE IN KII PENINSULA OF JAPAN , 1987, The Lancet.
[186] V. Palmer,et al. CYCAD USE AND MOTOR NEURONE DISEASE IN IRIAN JAYA , 1987, The Lancet.
[187] J. Mitchell,et al. Motor neurone disease in the Lothian Region of Scotland 1961-81. , 1986, Journal of epidemiology and community health.
[188] K. Tadera,et al. Hepatic and spinal lesions in goats chronically intoxicated with cycasin. , 1986, Nihon juigaku zasshi. The Japanese journal of veterinary science.
[189] M. Martínez Ferri,et al. [Conjugal amyotrophic lateral sclerosis]. , 1986, Neurologia.
[190] Y. Herishanu,et al. Motor neuron disease in textile factory workers , 1985, Israel journal of medical sciences.
[191] W. Bradley,et al. Amyotrophic leteral sclerosis: Part 2. Etiopathogenesis , 1985 .
[192] C. Andary,et al. Variations of monomethylhydrazine content in Gyromitra esculenta. , 1985 .
[193] R. Garruto,et al. Disappearance of high‐incidence amyotrophic lateral sclerosis and parkinsonism‐dementia on Guam , 1985, Neurology.
[194] E. Granieri,et al. Reply , 1984 .
[195] M. Giagheddu,et al. Epidemiologic study of amyotrophic lateral sclerosis in Sardinia, Italy , 1983, Acta neurologica Scandinavica.
[196] L. Pickle,et al. Geographic distribution of motor neuron disease and correlation with possible etiologic factors , 1983, Neurology.
[197] C. Warlow,et al. Motor neuron disease in England and Wales, 1959-1979. , 1983, Journal of neurology, neurosurgery, and psychiatry.
[198] C. Melmed,et al. A cluster of amyotrophic lateral sclerosis. , 1982, Archives of neurology.
[199] T. Munsat,et al. Conjugal motor neuron disease , 1982, Neurology.
[200] A. Salazar,et al. Amyotrophic lateral sclerosis and parkinsonian syndromes in high incidence among the Auyu and Jakai people of West New Guinea , 1982, Neurology.
[201] R. Garruto,et al. Amyotrophic lateral sclerosis and parkinsonism‐dementia among Filipino migrants to Guam , 1981, Annals of neurology.
[202] M. G. Macnaughton,et al. Effects of hydrazine on the activated sludge process , 1981 .
[203] S. De Flora,et al. DNA-damaging activity in vivo and bacterial mutagenicity of sixteen hydrazine derivatives as related quantitatively to their carcinogenicity. , 1981, Cancer research.
[204] C. Hawkes,et al. MOTOR NEURONE DISEASE IN LEATHER WORKERS , 1981, The Lancet.
[205] R. Garruto,et al. Amyotrophic lateral sclerosis among chamorro migrants from guam , 1980, Annals of neurology.
[206] M. Sanders. Clustering of amyotrophic lateral sclerosis. , 1980, JAMA.
[207] R. Adamson,et al. Carcinogenicity and hepatotoxicity of cycasin and its aglycone methylazoxymethanol acetate in nonhuman primates. , 1980, Journal of the National Cancer Institute.
[208] T. Winter,et al. Chemical oxygen scavengers: use of hydrazine and tannins for boiler water treatment , 1978 .
[209] Morris Pollard,et al. Induction of colon tumors in 1,2-dimethylhydrazine-resistant Lobund Wistar rats by methylazoxymethanol acetate. , 1978, Journal of the National Cancer Institute.
[210] B. Tóth,et al. Formation of methylhydrazine from acetaldehyde N-methyl-N-formylhydrazone, a component of Gyromitra esculenta. , 1977, Cancer research.
[211] A. W. Kilness,et al. Amyotrophic lateral sclerosis in a high selenium environment. , 1977, JAMA.
[212] H. Pyysalo. Tests for gyro mitrin, a poisonous compound in false morel gyromitra esculenta , 1976, Zeitschrift fur Lebensmittel-Untersuchung und -Forschung.
[213] B. Ames,et al. Hair dyes are mutagenic: identification of a variety of mutagenic ingredients. , 1975, Proceedings of the National Academy of Sciences of the United States of America.
[214] J. Brody,et al. Amyotrophic lateral sclerosis and parkinsonism-dementia on Guam, 1945-1972. I. Descriptive epidemiology. , 1975, American journal of epidemiology.
[215] J. Brody,et al. Amyotrophic lateral sclerosis and parkinsonism-dementia on Guam, 1945-1972. II. Familial and genetic studies. , 1975, American journal of epidemiology.
[216] F. Hochberg,et al. CLUSTERING OF AMYOTROPHIC LATERAL SCLEROSIS , 1974 .
[217] F. H. Shillito,et al. Pyridoxine and phenobarbital as treatment for aerozine-50 toxicity. , 1970, Aerospace medicine.
[218] H. Matsumoto,et al. Studies on Methylazoxymethanol , 1969, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[219] L. Kurland,et al. Amyotrophic lateral sclerosis-Parkinsonism dementia complex of Guam: further genetic investigations. , 1969, American journal of human genetics.
[220] R. C. Shank,et al. Similarities between the biochemical actions of cycasin and dimethylnitrosamine. , 1967, The Biochemical journal.
[221] P. List,et al. Gyromitrin, das gift der fruehjahrslorchel, gyromitra (helvella) esculenta fr.☆ , 1967 .
[222] H. Matsumoto,et al. Studies on methylazoxymethanol, the aglycone of cycasin: methylation of nucleic acids in vitro. , 1966, The Biochemical journal.
[223] H. Matsumoto,et al. STUDIES ON METHYLAZOXYMETHANOL, THE AGLYCONE OF CYCASIN. ISOLATION, BIOLOGICAL, AND CHEMICAL PROPERTIES. , 1965, Archives of biochemistry and biophysics.
[224] D. Dastur. CYCAD TOXICITY IN MONKEYS: CLINICAL, PATHOLOGICAL, AND BIOCHEMICAL ASPECTS. , 1964, Federation proceedings.
[225] A. Veis,et al. The action of hydrazine on collagen. I. Chemical modification. , 1963, The Journal of biological chemistry.
[226] D. L. Schoene,et al. Maleic Hydrazide, a Unique Growth Regulant. , 1949, Science.